YS Biopharma (NASDAQ: YS), formerly YishengBio, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. Learn more at www.ysbiopharm.com.
Location: China, Beijing
Employees: 11-50
Investors 2
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| 22.11.2023 | Adjuvant C... | adjuvantca... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 09.02.2024 | YS Biopharma Announces US$40 Million Private Placement Finan... | GAITHERSBURG, Md., Feb. 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopha... | en.prnasia... |